European Society for Translational Medicine (EUSTM)

  • Description
  • The Euro­pean Soci­ety for Trans­la­tional Med­i­cine (EUSTM) is a global non-​profit neu­tral plat­form for the advance­ment and progress of Trans­la­tional Med­i­cine by offer­ing high qual­ity edu­ca­tional pro­grams and events to the Society’s members.


    The soci­ety facil­i­tates coop­er­a­tion and inter­ac­tion among clin­i­cians, basic life sci­en­tists, acad­e­mia, indus­try, gov­ern­ments, fund­ing and reg­u­la­tory agen­cies, investors and pol­icy mak­ers in order to develop and deliver high qual­ity trans­la­tional med­i­cine pro­grams and ini­tia­tives with over­all aim to enhance the health care of global population.


    The society’s goal is to enhance the research and devel­op­ment of novel and afford­able diag­nos­tic tools and treat­ments for clin­i­cal dis­or­ders affect­ing global population.


    New Hori­zons in Trans­la­tional Med­i­cine (ISSN:23075023) is the offi­cial dig­i­tal mag­a­zine of the Euro­pean Soci­ety for Trans­la­tional Med­i­cine. New Hori­zons in Trans­la­tional Med­i­cine sum­ma­rize the lat­est indus­try trends and devel­op­ments, high­light R&D hur­dles and present poten­tial solu­tions to com­mon prob­lems encoun­tered in the Field. New Hori­zons in Trans­la­tional Med­i­cine also pub­lishes expert views from key opin­ion lead­ers (KOLs) and exec­u­tives from pharma, biotech and life sci­ence indus­try along with aca­d­e­mic lead­ers. New Hori­zons in Trans­la­tional Med­i­cine is pub­lished every month and dig­i­tally deliv­ered to more than 35,000 selected global exec­u­tives, clin­i­cal research pro­fes­sion­als and key opin­ion lead­ers (KOLs) from indus­try and academia.


    Phone +43.1.8923.562
    Location ,

    Social Networks and Comments